Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Herpes Simplex Keratitis Treatment Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The herpes simplex keratitis treatment ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
In a recent study published in the Virology Journal, a group of researchers evaluated the antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced ...
Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "HSV-1 Keratitis - Competitive Landscape, 2026" report has been added to ResearchAndMarkets.com's offering. This " HSV-1 Keratitis- Competitive landscape, ...
Ocular herpes simplex virus (HSV) infection is a global public health concern and a leading cause of infectious blindness. HSV type 1 predominantly affects the eye, establishing latency in the ...
Researchers from Excision Biotherapeutics Inc. and affiliated organizations have reported the development of a novel CRISPR/Cas9-mediated genome editing therapy – EBT-104 – for the treatment of latent ...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...
Compr Ophthalmol Update. 2005;6(2):85-101. In a 10-week study of three times daily oral acyclovir against placebo, pediatric patients with HSV stromal keratitis who were treated concomitantly with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results